NEO · ISSUER CIK 1077183
NEOGENOMICS INC
Between Aug 1, 2026 and Oct 29, 2026, 3 NEOGENOMICS INC insiders reported $0.00 of open-market purchases and $321K of sales on SEC Form 4.
↗3 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$321KInsider selling
−$321KNet open-market
Oct 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202616:29 | Oct 1, 2026 | NEO | Pres & Chief Operating Officer | M · Exercise | — | +17,562 | 198,640 | +10% | — | ||
| Oct 5, 202616:29 | Oct 1, 2026 | NEO | Pres & Chief Operating Officer | F · Tax | — | −6,911 | 191,729 | -3% | — | ||
| Sep 3, 202617:01 | Sep 1, 2026 | NEO | EVP, GC & Business Development | F · Tax | — | −2,692 | 90,875 | -3% | — | ||
| Aug 25, 202616:33 | Aug 21, 2026 | NEO | Pres & Chief Operating Officer | M · Exercise | — | +28,106 | 192,138 | +17% | — | ||
| Aug 25, 202616:33 | Aug 21, 2026 | NEO | Pres & Chief Operating Officer | F · Tax | — | −11,060 | 181,078 | -6% | — | ||
| Aug 6, 202616:02 | Aug 4, 2026 | NEO | Chief Accounting Officer | S · Sell | $16.07 | −20,000 | 5,153 | -80% | −$321K |